CASE CCC ANNUAL RETREAT
Registration Deadline is TODAY!
Today is the last day to register for the 2013 Case CCC Annual Scientific Retreat, July 11-12. The evening of July 11 will be held at the Wolstein Research Building and will feature a keynote address by Kenna Shaw from The Cancer Genome Atlas, followed by a cocktail reception and core facility posters. The retreat will continue on Friday, July 12 at Corporate College East. The day will be filled with interesting scientific sessions and lunchtime discussion tables. The day will wind down with a student poster session and cocktail reception.
If you are planning to attend, please go online and register today! All registrants should have received a confirmation email after registering. Please contact firstname.lastname@example.org if you didn't receive one to make sure we have you on our list.
CASE CCC IN THE NEWS
Reinventing Cancer Centers: Working Group Proposes "Equitable Schema" for Determining Cancer Center Core Grants
The Cancer Letter - Jul 5, 2013 (only available to subscribers)
Dr. Stan Gerson was quoted as part of an NCI-appointed Working Group that was formed to change the way core grants will be awarded in the future. The proposed new system would help younger and smaller centers to receive grant funding that reflects the quality of their science, as opposed to the age of the Center.
Keeping Cancer a Secret
New York Times - Jul 4, 2013
Wellness Blog by Mikkael A. Sekeres, MD. My patient came to see me every six months or so with his wife of 40 years, making the five-hour drive from West Virginia, where he managed a few businesses. He had myelodysplastic syndrome, a type of bone marrow cancer that in his case was indolent, requiring only regular shots with a hormone, but no chemotherapy – yet...
Cleveland Area Hospitals Ahead of the Pack Offering Low-dose CT Scans for Lung Cancer Screening
The Plain Dealer - Jul 4, 2013
It's been two years since a report in a prominent medical journal touted the use of low-dose computer tomography as a lung cancer screening tool...But in June of 2011 the New England Journal of Medicine published findings that reported that using low-dose CT instead of standard X-ray as a screening tool reduces the risk of dying from lung cancer by 20 percent in middle-age and elderly smokers. Those findings were from the National Cancer Institute's National Lung Screening Trial.
It was a week before the study appeared in NEJM, thatUniversity Hospitals began offering the service for $99. Five months later, Summa Western Reserve Hospital in Cuyahoga Falls started its screening program. The cost: $89.
Five months after that, in April 2012, came the Cleveland Clinic's program at a cost of $125...
Breast Tomosynthesis and the PACS: The Journey to Sustainable Workflow
Imaging Biz - Jun 18, 2013
With time of the essence, alternating between a standard PACS workstation and the proprietary Hologic workstation is not a viable option, for many facilities. The issue, as outlined by speaker Donna Plecha, MD, a radiologist with University Hospitals Case Medical Center (UHCMC), Cleveland, Ohio, is that the data issued by the Hologic breast-tomosynthesis system are in a proprietary format...
Applications to the Fiscal Year 2013 Prostate Cancer Research Program (PCRP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program(DHP), by the U.S. Army Medical Research Acquisitions Activity (USAMRAA).
- The PCRP Clinical Consortium Award provides the support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials. These trials will include investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of prostate cancer, especially as pertaining to the FY13 PCRP overarching challenges.
LOI Deadline: September 18
Application Deadline: October 9
- The PCRP Prostate Cancer Pathology Resource Network (PCPRN or Network) Award is intended to provide infrastructure support for the development and maintenance of a prostate cancer biorepository through a collaborative network across multiple institutions that will facilitate the collection, processing, annotation, storage, and distribution of high-quality human prostate cancer biospecimens. Biospecimens may be collected from the broad spectrum of prostate cancer clinical stages, but major emphasis must be placed on the acquisition and distribution of specimens in limited supply (e.g., castration-resistant disease, metastatic disease, tumors of the neuroendocrine phenotype, disproportionately affected populations, active surveillance populations, longitudinal specimens). The Network must also collect, store, and manage data derived from the distributed biospecimens, including images of the hematoxylin and eosin (H&E) stained samples. NEW for FY13: Applications will now be submitted by Coordinating Centers in collaboration with their chosen Pathology Resource Sites.
LOI Deadline: September 18
Application Deadline: October 9
MARK YOUR CALENDARS
MSC 2013: Adult Stem Cell Therapy & Regenerative Medicine
Mark your calendars for MSC 2013: Adult Stem Cell Therapy & Regenerative Medicine, August 19-21, 2013 at Cleveland Marriott Downtown at Key Center. Presented by the National Center for Regenerative Medicine, this conference will offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine. Online registration is open and poster abstracts are being accepted for presentation both in poster format and potentially accepted for platform presentation during the main program as well. Deadline is July 19 for poster abstract submission.